Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia
R. Formankova et al., Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia, BONE MAR TR, 25(4), 2000, pp. 453-456
Citations number
11
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
We report a case of a 13-year-old boy who was transplanted for relapse of a
cute myeloid leukemia (AML), A detailed study of hematopoietic chimerism wa
s performed using polymerase chain reaction (PCR) of variable number of tan
dem repeats (VNTR) at very short time intervals. We used discontinuation of
post-transplant immunosuppression and donor lymphocyte infusions (DLI) in
order to prevent leukemia relapse that was indicated by a progressive incre
ase in autologous hematopoiesis. Despite the fact that the boy relapsed 10
months after BMT, we could see a significant influence of adoptive immunoth
erapy on the mixed chimerism status during the post-transplant period.